Rapid MPT64-based immunochromatographic tests (MPT64 ICTs) have been developed to detect Mycobacterium tuberculosis complex (MTBC) in culture. We demonstrated the noninferiority of one commercial MTP64 ICT, the MGIT TBc identification (TBcID) test, to GenoType line probe assays for MTBC identification in positive MGIT cultures. Meta-analysis of MPT64 ICT performance for identification of MTBC in liquid culture confirmed similar very high sensitivities and specificities for all three commercial MPT64 assays for which sufficient data were available.
Rapid MPT64-based immunochromatographic tests (MPT64 ICTs) have been developed to detect Mycobacterium tuberculosis complex (MTBC) in culture. We demonstrated the noninferiority of one commercial MTP64 ICT, the MGIT TBc identification (TBcID) test, to GenoType line probe assays for MTBC identification in positive MGIT cultures. Meta-analysis of MPT64 ICT performance for identification of MTBC in liquid culture confirmed similar very high sensitivities and specificities for all three commercial MPT64 assays for which sufficient data were available.
Early tuberculosis case detection underpinned by qualityassured bacteriology is a cornerstone of the WHO Stop TB strategy (32) . WHO has endorsed wider implementation of liquid mycobacterial culture in high-burden countries to improve diagnostic sensitivity and culture turnaround times (29) (30) (31) . However, rapid and accurate identification of Mycobacterium tuberculosis in positive cultures is essential for translating these benefits into earlier diagnosis and treatment for patients-particularly as liquid culture is associated with isolation of more nontuberculous mycobacteria (NTM) (2, 31) . Conventional biochemical identification methods are slow, requiring subculture onto solid media, and cost and limited laboratory capacity preclude nucleic acid amplification tests (NAAT) in low-resource settings. Rapid immunochromatographic tests (ICT) that detect the M. tuberculosis complex (MTBC) MPT64 protein are cheaper and simpler to use and thus may have an important role in these and other settings. We compared one MPT64 ICT, the MGIT TBc identification test (TBc ID; Becton Dickinson, Sparks, MD), with the GenoType MTBC and Mycobacterium CM/AS line probe assays (LPA; Hain Lifescience Gmbh, Nehren, Germany) and present a meta-analysis of MPT64 assay performance for MTBC identification in liquid culture.
Between August 2009 and June 2011, clinical samples from two Kenyan hospitals were processed using the MGIT 960 system (BD Diagnostics, Sparks, MD) and standard protocols (3, 27) . Ziehl-Neelsen (ZN)-stained smears from positive cultures were examined for acid-fast bacilli (AFB), and an aliquot was inoculated onto blood agar to detect contamination (defined as growth after 48 h of incubation at 37°C). Further aliquots from AFB-positive cultures were used to perform TBcID and LPA according to manufacturers' instructions. When results were discordant, we repeated both tests, performed the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA) using the original specimen and culture broth, and reviewed the clinical notes. Assuming an LPA sensitivity of 99% (8) a These isolates were identified as members of the genus Mycobacteria, but the species was not identified using either the Genotype Mycobacterium CM or the Genotype Mycobacterium AS assay, which together include probes for 30 of the most common nontuberculous mycobacteria. ; P ϭ 0.500). We searched PubMed and Embase on 4 October 2011 for articles containing the terms "MPT64," "MPB64," "MGIT TBc," and/or "Capilia TB" to identify studies of MPT64 ICTs and then searched the reference lists of the articles to identify further relevant studies. No language restrictions were applied. We included in the meta-analysis studies that compared the performance of a commercial MPT64 ICT with the performance of another validated method for MTBC identification using AFB-positive liquid mycobacterial cultures and that presented results in sufficient detail to allow us to abstract the numbers of MTBC and non-MTBC isolates and MPT64 ICT true and false positive and negative results for liquid culture assays alone. In cases where an MPT64 ICT was repeated, measurements of diagnostic accuracy were based on the initial result, reflecting routine clinical laboratory practice. If discrepancies between reference methods were reported, the gold standard was defined by the majority test assignment (or by 16S rRNA sequencing where performed).
We identified 23 studies of commercial MPT64 ICTs (2, 4-6, 9-20, 22-26, 28, 33); 17 studies of 3 tests met inclusion criteria (Table 2) (2, 4-6, 9, 10, 12, 13, 16-18, 20, 22, 24-26, 28, 33) . Meta-analyses of the data, including data from the current study, demonstrated high sensitivity and specificity for all 3 tests, with high positive and negative predictive values for clinical isolates tested (Table 3 ). There was no evidence that sensitivities and specificities differed between tests even when we confined the meta-analysis to studies that used 16S rRNA sequencing or two or more independent, validated reference methods (4, 12, 16-18 (4) (5) (6) 33) . The mpb64 gene was sequenced for 27 of 53 (51%) clinically independent isolates for which the MPT64 ICT gave a false-negative result, and a mutation was demonstrated in 23 (85%) of those 27 isolates (12, 16, 17, 20, 22, 33 Our data and meta-analysis demonstrate noninferiority of MGIT TBcID to LPA for MTBC detection and similar high sensitivities and specificities of 3 commercial MPT64 assays across a range of geographical locations. A small minority of MTBC isolates are not detected by MPT64 assays due to deletion or mutation of the mpb64 gene (absent from some M. bovis BCG strains) (1, 12, 16, 17, 20, 22, 33) or to low MPT64 concentrations in early cultures (10, 18) or mixed cultures (10, 18) . The low cost and simplicity of MPT64 assays would outweigh the small reduction in sensitivity in most settings. Combining an MPT64 ICT with observation of AFB cording (2, 26) or a NAAT performed with MPT64-negative isolates (33) might further improve sensitivity. Since liquid culture contamination rates are high in some settings (2, 7, 21) , the 100% sensitivity and specificity of TBcID performed on contaminated AFB-positive cultures in this study are reassuring. Unlike some molecular assays, MPT64 ICTs do not incorporate drug susceptibility testing and cannot replace NAAT in all settings. Nevertheless, these data do provide strong support for their use as a rapid and reliable method for MTBC identification in liquid culture assays. 
